Financhill
Back

Hims & Hers Health Quote, Financials, Valuation and Earnings

Hims & Hers Health Price Quote

$9.41
-0.28 (-2.89%)
(Updated: March 23, 2023 at 4:10 PM ET)

Hims & Hers Health Key Stats

Buy
58
Hims & Hers Health (HIMS) is a Buy

Day range:
$9.68 - $10.02
52-week range:
$2.72 - $12.04
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
3.76
P/B ratio:
6.48%

Volume:
2.4M
Avg. volume:
3.8M
1-year change:
84.22%
Market cap:
$2B
Revenue:
$526.9M
EPS:
$-0.32

How Much Does Hims & Hers Health Make?

Is Hims & Hers Health Growing As A Company?

  • What Is Hims & Hers Health's Growth Rate Quarterly?
    Quarterly YoY revenue growth is 0.97%
  • What Is Hims & Hers Health's EPS Quarterly YoY Growth Rate?
    Quarterly, year-over-year diluted EPS growth rate is 0%

Hims & Hers Health Stock Price Performance

What Is Hims & Hers Health 52-Week High & Low?

Hims & Hers Health Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy Hims & Hers Health?

Is Hims & Hers Health Cash Flow Positive?

  • What Is HIMS Cash Flow From Operations?
    Cash flow from operations (TTM) is -$26.5M
  • What Is Hims & Hers Health’s Cash Flow From Financing?
    Cash flow from financing (TTM) is -$33.1M
  • What Is Hims & Hers Health’s Cash Flow From Investing?
    Cash flow from investing (TTM) is $34.7M

Hims & Hers Health Return On Invested Capital

  • Is Management Doing A Good Job?
    HIMS return on invested capital is -20.47%
  • What Is Hims & Hers Health Return On Assets?
    ROA measures how assets are converting to revenues and is -17%
  • What Is HIMS Return On Equity?
    ROE is a measure of profitability and is -20.47%

Hims & Hers Health Earnings Date & Stock Price

Hims & Hers Health Competitors

  • Who Are Hims & Hers Health's Competitors?
    Below is a list of companies who compete with Hims & Hers Health or are related in some way:
    • Clorox Co (CLX)
    • European Wax Center Inc (EWCZ)
    • Grove Collaborative Holdings Inc (GROV)
    • The Beauty Health Co (SKIN)
    • Sentient Brands Holdings Inc (SNBH)

Hims & Hers Health Dividend Yield

Data Unavailable

Hims & Hers Health Analyst Estimates

YoY Growth Past Surprise
EPS: 0% -159.53%
Revenue: 97.41% 3.74%

Analyst Recommendations

Buy Recommendations: 4
Hold Recommendations: 4
Sell Recommendations: 0
Price Target: 11.95
Upside from Last Price: 23.32%

Major Shareholders

  • How many HIMS shares are owned by institutional investors?
    145.9M HIMS shares are owned by institutional investors
  • How many HIMS shares are owned by insiders?
    1.8M HIMS shares are owned by insiders